Shaomeng Wang

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
1
2
12
4
8
8
6
9
7
12
4
8
6
2
2002
2003
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2017
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
1
1995
UNIVERSITY OF KANSAS
2
2012
ASCENTA LICENSING CORPORATION
2
2
2011
2014
GEORGETOWN UNIVERSITY
1
3
1
5
2
3
1
5
1
1998
1999
2000
2001
2002
2003
2007
2008
2009
Jiangsu Ascentage Biomed Development Inc.
2
2014
SANOFI
2
2
2
2011
2012
2014
ADHEREX TECHNOLOGIES, INC.
2
2003

Inventor Addresses

AddressDuration
Ann Arbor, MIJun 16, 05 - Mar 06, 08
Ann Arbor, MI, USMar 25, 21 - Nov 18, 21
Chengdu, Sichuan, CNMar 24, 22 - Mar 24, 22
Hangzhou, CNNov 29, 18 - Mar 15, 22
MCLEAN, VAApr 11, 02 - Apr 11, 02
McLean, VANov 07, 00 - Nov 07, 00
McLeane, VAOct 05, 99 - Sep 04, 01
Rockville, MDFeb 23, 99 - Apr 08, 08
Rockville, MD, USMay 15, 03 - May 15, 03
Saline, MIJan 09, 03 - Oct 09, 08
Saline, MI, USSep 26, 02 - Aug 29, 17
Sichuan, CNApr 19, 22 - Apr 19, 22
Superior Township, MI, USMar 09, 17 - Jan 30, 25
Superior Towship, MI, USJan 23, 20 - Jan 23, 20

Technology Profile

Technology Matters
A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 4
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 89
A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2025/0034,1622025IMIDAZOPYRIMIDINES AS EED INHIBITORS AND THE USE THEREOF0
121459442024Imidazopyrimidines as EED inhibitors and the use thereof0
120124672024Small molecule DCN1 inhibitors and therapeutic methods using the same0
2024/0190,8742024SMALL MOLECULE DEGRADERS OF ANDROGEN RECEPTOR0
2024/0190,8802024SMALL MOLECULE DEGRADERS OF ESTROGEN RECEPTOR WITH CEREBLON LIGANDS0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.